Together, these results provided further validation for 14/15 (no confirmation for VAPA) of our potential diagnostic biomarkers in distinguishing between Luminal-like breast cancers utilizing clinical tissue data and are summarized in Fig. 8B. The gene discussed is VAPA; the disease is breast cancer.